Pharmacovigilance Posts | JPCC Associates

top of page

Contact@JPCCAssociates.com

JPCC ASSOCIATES

PV Consulting by PV Professionals

Search

Protocol Deviations and Serious Breach Expedited Reporting

Protocol Deviations and Serious Breach Expedited Reporting

Protocol Deviations and Serious Breach Expedited Reporting

Jean-Pierre (JP) Clement

May 19, 20172 min read

The Four Cornerstones of a Pharmacovigilance Organization

The Four Cornerstones of a Pharmacovigilance Organization

The Four Cornerstones of a Pharmacovigilance Organization

Jean-Pierre (JP) Clement

May 8, 20173 min read

How to Establish a Solid PV Training Curriculum?

How to Establish a Solid PV Training Curriculum?

How to Establish a Solid PV Training Curriculum?

Jean-Pierre (JP) Clement

Apr 5, 20173 min read

Building PV SOPs: Where to start?

Building PV SOPs: Where to start?

Building PV SOPs: Where to start?

Jean-Pierre (JP) Clement

Mar 17, 20174 min read

PV Audit by Quality: Friends or Foes?

PV Audit by Quality: Friends or Foes?

PV Audit by Quality: Friends or Foes?

Jean-Pierre (JP) Clement

Mar 9, 20173 min read

The Art of CAPA Writing

The Art of CAPA Writing

The Art of CAPA Writing

Jean-Pierre (JP) Clement

Feb 13, 20173 min read

Outsourcing PV: Keys for a Successful Partnership

Outsourcing PV: Keys for a Successful Partnership

Outsourcing PV: Keys for a Successful Partnership

Jean-Pierre (JP) Clement

Jan 25, 20173 min read

Outsourcing PV: Selecting your Partner

Outsourcing PV: Selecting your Partner

Outsourcing PV: Selecting your Partner

Jean-Pierre (JP) Clement

Jan 23, 20173 min read

Outsourcing PV: Core Competencies

Outsourcing PV: Core Competencies

Outsourcing PV: Core Competencies

Jean-Pierre (JP) Clement

Dec 7, 20165 min read

Outsourcing PV: Key Decision Drivers

Outsourcing PV: Key Decision Drivers

Outsourcing PV: Key Decision Drivers

Jean-Pierre (JP) Clement

Nov 2, 20163 min read

Crisis Prevention in Pharmacovigilance

Crisis Prevention in Pharmacovigilance

Crisis Prevention in Pharmacovigilance

Jean-Pierre (JP) Clement

Oct 12, 20165 min read

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Report

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Report

The New Clinical Trial Directive, Low Risk Intervention Clinical Trials and Pharmacovigilance Report

Jean-Pierre (JP) Clement

Oct 3, 20163 min read

The Expanding Role of PV in Pre-marketing Activities

The Expanding Role of PV in Pre-marketing Activities

The Expanding Role of PV in Pre-marketing Activities

Jean-Pierre (JP) Clement

Sep 7, 20163 min read

What do Pharmacovigilance and Market Research Programs have in common?

What do Pharmacovigilance and Market Research Programs have in common?

What do Pharmacovigilance and Market Research Programs have in common?

Jean-Pierre (JP) Clement

Sep 2, 20164 min read

Compliance Metrics for Pharmacovigilance Activities

Compliance Metrics for Pharmacovigilance Activities

Compliance Metrics for Pharmacovigilance Activities

Jean-Pierre (JP) Clement

Aug 19, 20163 min read

The Changing Competencies of Pharmacovigilance Leadership

The Changing Competencies of Pharmacovigilance Leadership

The Changing Competencies of Pharmacovigilance Leadership

Jean-Pierre (JP) Clement

Jun 27, 20164 min read

Did you just say Safety Governance Model?

Did you just say Safety Governance Model?

Did you just say Safety Governance Model?

Jean-Pierre (JP) Clement

May 27, 20163 min read

Practical aspects of the “new” IND Rule

Practical aspects of the “new” IND Rule

Practical aspects of the “new” IND Rule

Jean-Pierre (JP) Clement

May 23, 20164 min read

bottom of page